Loading…
STUDY ON THERAPEUTIC OUTCOME, ATTITUDE AND AWARENESS ABOUT TYPE-2 DIABETES AMONG TYPE-2 DIABETIC FEMALE PATIENTS IN ASEER DIABETIC CENTER
Type 2 diabetes mellitus (T2DM) is a global epidemic problem. Obesity is the single most important contributor to insulin resistance. Management of diabetes requires lifestyle modification (eg. dietary changes and physical activity) and adherence to other healthful behaviors, such as medication adhe...
Saved in:
Published in: | Pharmacie Globale : International Journal of Comprehensive Pharmacy 2014-01, Vol.5 (1), p.1 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 1 |
container_start_page | 1 |
container_title | Pharmacie Globale : International Journal of Comprehensive Pharmacy |
container_volume | 5 |
creator | Khan, Noohu Abdulla Venkatachalam, V V Alavudeen, Sirajudeen S Alakhali, Khaled M Dhanapal, C K |
description | Type 2 diabetes mellitus (T2DM) is a global epidemic problem. Obesity is the single most important contributor to insulin resistance. Management of diabetes requires lifestyle modification (eg. dietary changes and physical activity) and adherence to other healthful behaviors, such as medication adherence, and timely medical care. This is a cross sectional retrospective cum prospective study of patients which included all adult type 2 DM patients who were registered in the Aseer diabetic center, Abha, Aseer Region, Kingdom of Saudi Arabia. This study was conducted from July, 2012 to October 2013.As a therapeutic outcome the HbA1c target was not achieved in this group of patients. In all the four visits the mean target value for Glycated hemoglobin (HbA1c) was found to be above 9% and there is no significance difference in reduction of HbA1c after treatment. There is no significance difference or improvement in the lipid profile except total cholesterol and VLDL among this group of patients. Only (31.88%) of the patients was following SMBG. Patients not taking medications in proper time as prescribed were about (30.35%). Forget fullness was the main reason for not taking the medication on time. Increased duration of diabetes and obesity was associated with higher incidence of Hyperglycemia and dyslipidemia. Lack of awareness and poor compliance to therapeutic management created huge burden on healthcare system in the kingdom. Patient education and awareness programs should be done to improve the present situation. [PUBLICATION ABSTRACT] |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1525960045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3308141111</sourcerecordid><originalsourceid>FETCH-proquest_journals_15259600453</originalsourceid><addsrcrecordid>eNqNjLsKwkAQRRdRUNR_GLA1sD42xnJMRl0wm5CdIFbBQgsRH4n5CP_aLQS1c5p7OfcwDdGR85nvBSM1a371tuhX1Um6C6T0peqIp-U82kFigNeUYUo56xCSnMMkpiEgs3YCAZoIcIsZGbIWcOEM4F1K3hgijQticjROzOqXul9LinFDkCJrMmxBG0BLlH2M0HHKeqJ13J-rQ_-dXTFYEodr71Ze7_WhehSna11e3FSM1FjNfSmnavKf9QJ9aUfU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1525960045</pqid></control><display><type>article</type><title>STUDY ON THERAPEUTIC OUTCOME, ATTITUDE AND AWARENESS ABOUT TYPE-2 DIABETES AMONG TYPE-2 DIABETIC FEMALE PATIENTS IN ASEER DIABETIC CENTER</title><source>Publicly Available Content Database</source><creator>Khan, Noohu Abdulla ; Venkatachalam, V V ; Alavudeen, Sirajudeen S ; Alakhali, Khaled M ; Dhanapal, C K</creator><creatorcontrib>Khan, Noohu Abdulla ; Venkatachalam, V V ; Alavudeen, Sirajudeen S ; Alakhali, Khaled M ; Dhanapal, C K</creatorcontrib><description>Type 2 diabetes mellitus (T2DM) is a global epidemic problem. Obesity is the single most important contributor to insulin resistance. Management of diabetes requires lifestyle modification (eg. dietary changes and physical activity) and adherence to other healthful behaviors, such as medication adherence, and timely medical care. This is a cross sectional retrospective cum prospective study of patients which included all adult type 2 DM patients who were registered in the Aseer diabetic center, Abha, Aseer Region, Kingdom of Saudi Arabia. This study was conducted from July, 2012 to October 2013.As a therapeutic outcome the HbA1c target was not achieved in this group of patients. In all the four visits the mean target value for Glycated hemoglobin (HbA1c) was found to be above 9% and there is no significance difference in reduction of HbA1c after treatment. There is no significance difference or improvement in the lipid profile except total cholesterol and VLDL among this group of patients. Only (31.88%) of the patients was following SMBG. Patients not taking medications in proper time as prescribed were about (30.35%). Forget fullness was the main reason for not taking the medication on time. Increased duration of diabetes and obesity was associated with higher incidence of Hyperglycemia and dyslipidemia. Lack of awareness and poor compliance to therapeutic management created huge burden on healthcare system in the kingdom. Patient education and awareness programs should be done to improve the present situation. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0976-8157</identifier><identifier>EISSN: 0976-8157</identifier><language>eng</language><publisher>Roorkee: Pharmacie Globale</publisher><ispartof>Pharmacie Globale : International Journal of Comprehensive Pharmacy, 2014-01, Vol.5 (1), p.1</ispartof><rights>Copyright Pharmacie Globale Jan-Mar 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1525960045/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1525960045?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,25735,36994,44572,74876</link.rule.ids></links><search><creatorcontrib>Khan, Noohu Abdulla</creatorcontrib><creatorcontrib>Venkatachalam, V V</creatorcontrib><creatorcontrib>Alavudeen, Sirajudeen S</creatorcontrib><creatorcontrib>Alakhali, Khaled M</creatorcontrib><creatorcontrib>Dhanapal, C K</creatorcontrib><title>STUDY ON THERAPEUTIC OUTCOME, ATTITUDE AND AWARENESS ABOUT TYPE-2 DIABETES AMONG TYPE-2 DIABETIC FEMALE PATIENTS IN ASEER DIABETIC CENTER</title><title>Pharmacie Globale : International Journal of Comprehensive Pharmacy</title><description>Type 2 diabetes mellitus (T2DM) is a global epidemic problem. Obesity is the single most important contributor to insulin resistance. Management of diabetes requires lifestyle modification (eg. dietary changes and physical activity) and adherence to other healthful behaviors, such as medication adherence, and timely medical care. This is a cross sectional retrospective cum prospective study of patients which included all adult type 2 DM patients who were registered in the Aseer diabetic center, Abha, Aseer Region, Kingdom of Saudi Arabia. This study was conducted from July, 2012 to October 2013.As a therapeutic outcome the HbA1c target was not achieved in this group of patients. In all the four visits the mean target value for Glycated hemoglobin (HbA1c) was found to be above 9% and there is no significance difference in reduction of HbA1c after treatment. There is no significance difference or improvement in the lipid profile except total cholesterol and VLDL among this group of patients. Only (31.88%) of the patients was following SMBG. Patients not taking medications in proper time as prescribed were about (30.35%). Forget fullness was the main reason for not taking the medication on time. Increased duration of diabetes and obesity was associated with higher incidence of Hyperglycemia and dyslipidemia. Lack of awareness and poor compliance to therapeutic management created huge burden on healthcare system in the kingdom. Patient education and awareness programs should be done to improve the present situation. [PUBLICATION ABSTRACT]</description><issn>0976-8157</issn><issn>0976-8157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNjLsKwkAQRRdRUNR_GLA1sD42xnJMRl0wm5CdIFbBQgsRH4n5CP_aLQS1c5p7OfcwDdGR85nvBSM1a371tuhX1Um6C6T0peqIp-U82kFigNeUYUo56xCSnMMkpiEgs3YCAZoIcIsZGbIWcOEM4F1K3hgijQticjROzOqXul9LinFDkCJrMmxBG0BLlH2M0HHKeqJ13J-rQ_-dXTFYEodr71Ze7_WhehSna11e3FSM1FjNfSmnavKf9QJ9aUfU</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Khan, Noohu Abdulla</creator><creator>Venkatachalam, V V</creator><creator>Alavudeen, Sirajudeen S</creator><creator>Alakhali, Khaled M</creator><creator>Dhanapal, C K</creator><general>Pharmacie Globale</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M7Z</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20140101</creationdate><title>STUDY ON THERAPEUTIC OUTCOME, ATTITUDE AND AWARENESS ABOUT TYPE-2 DIABETES AMONG TYPE-2 DIABETIC FEMALE PATIENTS IN ASEER DIABETIC CENTER</title><author>Khan, Noohu Abdulla ; Venkatachalam, V V ; Alavudeen, Sirajudeen S ; Alakhali, Khaled M ; Dhanapal, C K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_15259600453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Noohu Abdulla</creatorcontrib><creatorcontrib>Venkatachalam, V V</creatorcontrib><creatorcontrib>Alavudeen, Sirajudeen S</creatorcontrib><creatorcontrib>Alakhali, Khaled M</creatorcontrib><creatorcontrib>Dhanapal, C K</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Pharmacie Globale : International Journal of Comprehensive Pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Noohu Abdulla</au><au>Venkatachalam, V V</au><au>Alavudeen, Sirajudeen S</au><au>Alakhali, Khaled M</au><au>Dhanapal, C K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>STUDY ON THERAPEUTIC OUTCOME, ATTITUDE AND AWARENESS ABOUT TYPE-2 DIABETES AMONG TYPE-2 DIABETIC FEMALE PATIENTS IN ASEER DIABETIC CENTER</atitle><jtitle>Pharmacie Globale : International Journal of Comprehensive Pharmacy</jtitle><date>2014-01-01</date><risdate>2014</risdate><volume>5</volume><issue>1</issue><spage>1</spage><pages>1-</pages><issn>0976-8157</issn><eissn>0976-8157</eissn><abstract>Type 2 diabetes mellitus (T2DM) is a global epidemic problem. Obesity is the single most important contributor to insulin resistance. Management of diabetes requires lifestyle modification (eg. dietary changes and physical activity) and adherence to other healthful behaviors, such as medication adherence, and timely medical care. This is a cross sectional retrospective cum prospective study of patients which included all adult type 2 DM patients who were registered in the Aseer diabetic center, Abha, Aseer Region, Kingdom of Saudi Arabia. This study was conducted from July, 2012 to October 2013.As a therapeutic outcome the HbA1c target was not achieved in this group of patients. In all the four visits the mean target value for Glycated hemoglobin (HbA1c) was found to be above 9% and there is no significance difference in reduction of HbA1c after treatment. There is no significance difference or improvement in the lipid profile except total cholesterol and VLDL among this group of patients. Only (31.88%) of the patients was following SMBG. Patients not taking medications in proper time as prescribed were about (30.35%). Forget fullness was the main reason for not taking the medication on time. Increased duration of diabetes and obesity was associated with higher incidence of Hyperglycemia and dyslipidemia. Lack of awareness and poor compliance to therapeutic management created huge burden on healthcare system in the kingdom. Patient education and awareness programs should be done to improve the present situation. [PUBLICATION ABSTRACT]</abstract><cop>Roorkee</cop><pub>Pharmacie Globale</pub><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0976-8157 |
ispartof | Pharmacie Globale : International Journal of Comprehensive Pharmacy, 2014-01, Vol.5 (1), p.1 |
issn | 0976-8157 0976-8157 |
language | eng |
recordid | cdi_proquest_journals_1525960045 |
source | Publicly Available Content Database |
title | STUDY ON THERAPEUTIC OUTCOME, ATTITUDE AND AWARENESS ABOUT TYPE-2 DIABETES AMONG TYPE-2 DIABETIC FEMALE PATIENTS IN ASEER DIABETIC CENTER |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A32%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=STUDY%20ON%20THERAPEUTIC%20OUTCOME,%20ATTITUDE%20AND%20AWARENESS%20ABOUT%20TYPE-2%20DIABETES%20AMONG%20TYPE-2%20DIABETIC%20FEMALE%20PATIENTS%20IN%20ASEER%20DIABETIC%20CENTER&rft.jtitle=Pharmacie%20Globale%20:%20International%20Journal%20of%20Comprehensive%20Pharmacy&rft.au=Khan,%20Noohu%20Abdulla&rft.date=2014-01-01&rft.volume=5&rft.issue=1&rft.spage=1&rft.pages=1-&rft.issn=0976-8157&rft.eissn=0976-8157&rft_id=info:doi/&rft_dat=%3Cproquest%3E3308141111%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_15259600453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1525960045&rft_id=info:pmid/&rfr_iscdi=true |